HS/CN-koodi 293790 on soveltamisalan ulkopuolella EUDR-valmistelun kannalta.
Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10) Indeksoitu soveltamisalamoottori palauttaa arvon Out of scope tälle koodille. No Annex I scope match was found for this indexed CN code.
Miksi tämä hakemistosivu antaa tämän vastauksen.
- Koodin kuvaus
- Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
- Liite I -peruste
- Ei suoraa liite I -merkintää
- Lähdeperuste
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Yläkoodi, alakoodit ja lähirivit.
Kirjastonäkymä on tarkoitettu viitenavigointiin. Käytä tarkistinta, kun haluat suorittaa toisen koodin toimintona.
29ryhmä - orgaaniset kemialliset yhdisteetnarrower2937hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof "incl. chain modified polypeptides", used primarily as hormonesout29379000hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)(2012-2500);hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives)(2002-2011)out293710pituitary "anterior" or similar hormones, and derivatives, used primarily as hormonesout293711somatropin, its derivatives and structural analogues, used primarily as hormonesout293712insulin and its salts, used primarily as hormonesout293719polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)out293721cortisone, hydrocortisone, prednisone "dehydrocortisone" and prednisolone "dehydrohydrocortisone"out293722halogenated derivatives of corticosteroidal hormonesout
Mitä tämä tarkoittaa valmistelun kannalta.
Tämä rivi ei ole suora näytönkeruun laukaisin nykyisessä soveltamisalatuloksessa.
Regulation (EU) 2023/1115 Annex I — relevant productshaettu 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115haettu 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)haettu 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)haettu 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8haettu 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkinghaettu 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradershaettu 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)haettu 2026-08-08